Literature DB >> 24957320

Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.

Michael L LeFevre.   

Abstract

DESCRIPTION: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for abdominal aortic aneurysm (AAA).
METHODS: The USPSTF commissioned a systematic review that assessed the evidence on the benefits and harms of screening for AAA and strategies for managing small (3.0 to 5.4 cm) screen-detected AAAs. POPULATION: These recommendations apply to asymptomatic adults aged 50 years or older. RECOMMENDATION: The USPSTF recommends 1-time screening for AAA with ultrasonography in men aged 65 to 75 years who have ever smoked. (B recommendation). The USPSTF recommends that clinicians selectively offer screening for AAA in men aged 65 to 75 years who have never smoked. (C recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for AAA in women aged 65 to 75 years who have ever smoked. (I statement). The USPSTF recommends against routine screening for AAA in women who have never smoked. (D recommendation).

Entities:  

Mesh:

Year:  2014        PMID: 24957320     DOI: 10.7326/M14-1204

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  62 in total

Review 1.  Abdominal aortic aneurysm screening: concepts and controversies.

Authors:  Evan J Zucker; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 2.  Current status of the treatment of infrarenal abdominal aortic aneurysms.

Authors:  Linda J Wang; Anand M Prabhakar; Christopher J Kwolek
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 3.  Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.

Authors:  Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

4.  Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Authors:  Yasuhiko Kubota; Aaron R Folsom; Christie M Ballantyne; Weihong Tang
Journal:  Atherosclerosis       Date:  2017-11-26       Impact factor: 5.162

Review 5.  Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.

Authors:  Matthew A Dale; Melissa K Ruhlman; B Timothy Baxter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

6.  Effect of endovascular therapy on the expression levels of serum T lymphocyte subsets, Notch1 and TACE proteins in patients with abdominal aortic aneurysm.

Authors:  Hao Yan; Hong Jiang; Qian Xia; Wei Shan; Liwei Zhang; Fan Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 7.  Re-evaluating the Appropriateness of Non-invasive Arterial Vascular Imaging and Diagnostic Modalities.

Authors:  Jason M Misher; Andrew M Galmer; Mitchell W Weinberg; John S Pellerito; Joe F Lau
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

8.  [Choosing wisely recommendations in angiology].

Authors:  O J Müller; R Sternitzky
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

9.  Association of Life's Simple 7 with reduced clinically manifest abdominal aortic aneurysm: The ARIC study.

Authors:  Abayomi O Oyenuga; Aaron R Folsom; Pamela L Lutsey; Weihong Tang
Journal:  Vasc Med       Date:  2019-03-21       Impact factor: 3.239

10.  TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.

Authors:  Stoyan N Angelov; Jie Hong Hu; Hao Wei; Nathan Airhart; Minghui Shi; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-20       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.